arrow
K

Kate Wilson

national health & medical research council (nhmrc) of australia
H指数:29
被引数:7,420

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial

[177Lu]Lu-DOTATATE PRRT与CAPTEM化疗治疗胰腺和小肠神经内分泌肿瘤:AGITG CONTROL NETS多中心随机试验

2026-05-090
PRE
RoLaCaRT-1: pilot randomised phase II study of robotic vs laparoscopic hemicolectomy for right colon cancer

RoLaCaRT-1:机器人辅助与腹腔镜右半结肠切除术治疗右半结肠癌的随机对照Ⅱ期临床研究

2025-12-010
OA
Cellular and Cell-Free Genomic Characterization of Patients Receiving Avatrombopag and Immunosuppressive Therapy for Treatment-Naïve Severe Aplastic Anemia

接受Avatrombopag和免疫抑制疗法治疗初治重型再生障碍性贫血患者的细胞及无细胞基因组特征

BLOOD
IF23.1
2024-11-050
PRE
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
2023-05-319
OAAI
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
LANCET
IF88.5
2022-09-01123
OAAI
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials
LANCET
IF88.5
2022-09-0147
OAAI
Patient-Reported Bowel, Urinary, and Sexual Outcomes After Laparoscopic-Assisted Resection or Open Resection for Rectal Cancer The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial (ALaCart)

腹腔镜辅助直肠癌切除术或开腹直肠癌切除术后患者报告的肠,尿和性结局澳大利亚腹腔镜直肠癌随机临床试验 (ALaCart)

2022-02-159
PRE
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer

Vegf-a,VEGFR1和VEGFR2单核苷酸多态性与卡培他滨,贝伐单抗和丝裂霉素c治疗转移性结直肠癌的AGITG MAX试验的结果

2022-01-2413
OAAI
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer

AGITG总体规划:一项针对高危及局部晚期胰腺癌患者的随机II期研究,比较改良FOLFIRINOX单药治疗与联合立体定向体部放射治疗的疗效。

2021-08-1913
OAAI
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

MONARCC: 帕尼单抗单药治疗和帕尼单抗联合5-氟尿嘧啶作为RAS和BRAF野生型转移性结直肠癌一线治疗的随机II期研究: 澳大利亚胃肠道试验组 (AGITG) 的研究

2021-08-181
OAAI
Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

AGITG医生的患者报告结果 (PRO) 结果: 一项针对可切除食管腺癌的定制新辅助治疗的随机II期试验

2020-09-010
OAAI
Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa
2020-07-0720
OAAI